Skip to main content
Caplight Logo









Avails Medical

Avails Medical

Private
Menlo Park, CaliforniaHealthcare & Life Scienceshttps://availsmedical.com/

Last Round

Grant

Jun 12, 2023

Total Funding Raised

$12.83M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Avails Medical is an in-vitro diagnostics company that develops rapid, automated, and all-electrical antibiotic susceptibility testing platforms to combat antibiotic resistance.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS

AI Layer

Application

Keywords

antibiotic susceptibility testingASTrapid diagnosticsbloodstream infectionssepsis diagnosticselectronic biosensorclinical microbiologypathogen quantificationmedical deviceantimicrobial resistancelab automationrazor and bladepoint of care testing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Avails Medical Comparables

Compare Avails Medical with similar companies based on industry and business-model similarity.

Avails Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
SeLux Diagnostics
89%
HelixBind
86%
Resistell AG
86%

Avails Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJun 12, 2023
GrantSep 1, 2022
GrantFeb 1, 2021
Early FundingMar 24, 2020
GrantJul 1, 2016
Seed
Mar 24, 2016

Key People

Founding team and executive leadership

Meike Herget

Co-founder CTO

Founding Team

Oren Knopfmacher

Chief Everything Officer & Co-Founder

Founding Team

Avails Medical Investors

Notable investors and investment history

Avails Medical investors
InvestorRounds
CARB-XGrant
NIH RADxGrant
Omron VenturesEarly Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 19, 2026

    Monthly visitors increased 31% MoM, reaching 2.3K.

  • Apr 27, 2026

    Developing eAST, a next-generation system for rapid antibiotic susceptibility testing.

Avails Medical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Avails Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Avails Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersMenlo Park, California
Employee Range45
Year Founded2013
Last FundingJun 12, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?